speb/financial-data huggingface dataset:
IMR.V cash_flow (annual, 2024-05-31) — Change In Payable: 99595.00
IMR.V cash_flow (annual, 2024-05-31) — Change In Payables And Accrued Expense: 99595.00
IMR.V cash_flow (annual, 2024-05-31) — Change In Prepaid Assets: 79311.00
IMR.V cash_flow (annual, 2024-05-31) — Change In Receivables: 88222.00
IMR.V cash_flow (annual, 2024-05-31) — Change In Working Capital: 267128.00
IMR.V cash_flow (annual, 2024-05-31) — Changes In Cash: -881170.00
IMR.V balance_sheet (annual, 2024-05-31) — Common Stock: 49454484.00
IMR.V balance_sheet (annual, 2024-05-31) — Common Stock Equity: 5116503.00
IMR.V cash_flow (annual, 2024-05-31) — Common Stock Issuance: 364000.00
IMR.V income_statement (annual, 2024-05-31) — Cost Of Revenue: 1778.00
IMR.V balance_sheet (annual, 2024-05-31) — Current Assets: 85448.00
IMR.V balance_sheet (annual, 2024-05-31) — Current Liabilities: 678824.00
IMR.V cash_flow (annual, 2024-05-31) — Depreciation: 1778.00
IMR.V cash_flow (annual, 2024-05-31) — Depreciation Amortization Depletion: 1778.00
IMR.V cash_flow (annual, 2024-05-31) — Depreciation And Amortization: 1778.00
IMR.V income_statement (annual, 2024-05-31) — Diluted Average Shares: 5329490.00
IMR.V income_statement (annual, 2024-05-31) — Diluted EPS: -0.43
IMR.V income_statement (annual, 2024-05-31) — Diluted NI Availto Com Stockholders: -2264170.00
IMR.V balance_sheet (annual, 2024-05-31) — Dueto Related Parties Current: 163010.00
IMR.V income_statement (annual, 2024-05-31) — EBIT: -2247516.00
IMR.V income_statement (annual, 2024-05-31) — EBITDA: -2245738.00
IMR.V cash_flow (annual, 2024-05-31) — End Cash Position: 12369.00
IMR.V cash_flow (annual, 2024-05-31) — Financing Cash Flow: 338520.00
IMR.V cash_flow (annual, 2024-05-31) — Free Cash Flow: -1219690.00
IMR.V balance_sheet (annual, 2024-05-31) — Gains Losses Not Affecting Retained Earnings: 4675092.00
IMR.V income_statement (annual, 2024-05-31) — General And Administrative Expense: 555959.00
IMR.V balance_sheet (annual, 2024-05-31) — Gross PPE: 5734775.00
IMR.V income_statement (annual, 2024-05-31) — Gross Profit: -1778.00
IMR.V income_statement (annual, 2024-05-31) — Impairment Of Capital Assets: 1189513.00
IMR.V income_statement (annual, 2024-05-31) — Interest Expense: 16654.00
IMR.V income_statement (annual, 2024-05-31) — Interest Expense Non Operating: 16654.00
IMR.V balance_sheet (annual, 2024-05-31) — Invested Capital: 5116503.00
IMR.V cash_flow (annual, 2024-05-31) — Investing Cash Flow: -393623.00
IMR.V cash_flow (annual, 2024-05-31) — Issuance Of Capital Stock: 364000.00
IMR.V balance_sheet (annual, 2024-05-31) — Machinery Furniture Equipment: 29046.00
IMR.V cash_flow (annual, 2024-05-31) — Net Common Stock Issuance: 364000.00
IMR.V income_statement (annual, 2024-05-31) — Net Income: -2264170.00
IMR.V income_statement (annual, 2024-05-31) — Net Income Common Stockholders: -2264170.00
IMR.V income_statement (annual, 2024-05-31) — Net Income Continuous Operations: -2264170.00
IMR.V income_statement (annual, 2024-05-31) — Net Income From Continuing And Discontinued Operation: -2264170.00
IMR.V income_statement (annual, 2024-05-31) — Net Income From Continuing Operation Net Minority Interest: -2264170.00
IMR.V cash_flow (annual, 2024-05-31) — Net Income From Continuing Operations: -2264170.00
IMR.V income_statement (annual, 2024-05-31) — Net Income Including Noncontrolling Interests: -2264170.00
IMR.V income_statement (annual, 2024-05-31) — Net Interest Income: -16654.00
IMR.V income_statement (annual, 2024-05-31) — Net Non Operating Interest Income Expense: -16654.00
IMR.V cash_flow (annual, 2024-05-31) — Net Other Financing Charges: -25480.00
IMR.V balance_sheet (annual, 2024-05-31) — Net PPE: 5709879.00
IMR.V cash_flow (annual, 2024-05-31) — Net PPE Purchase And Sale: -393623.00
IMR.V balance_sheet (annual, 2024-05-31) — Net Tangible Assets: 5116503.00
IMR.V income_statement (annual, 2024-05-31) — Normalized EBITDA: -1056225.00
IMR.V income_statement (annual, 2024-05-31) — Normalized Income: -1074657.00
IMR.V cash_flow (annual, 2024-05-31) — Operating Cash Flow: -826067.00
IMR.V income_statement (annual, 2024-05-31) — Operating Income: -1101265.00
IMR.V income_statement (annual, 2024-05-31) — Operating Revenue: 0.00
IMR.V balance_sheet (annual, 2024-05-31) — Ordinary Shares Number: 5607960.00
IMR.V balance_sheet (annual, 2024-05-31) — Other Current Liabilities: 81537.00
IMR.V income_statement (annual, 2024-05-31) — Other Gand A: 515013.00
IMR.V income_statement (annual, 2024-05-31) — Other Income Expense: -1146251.00
IMR.V cash_flow (annual, 2024-05-31) — Other Non Cash Items: -43262.00
IMR.V income_statement (annual, 2024-05-31) — Other Non Operating Income Expenses: 43262.00
IMR.V income_statement (annual, 2024-05-31) — Other Operating Expenses: 81989.00
IMR.V balance_sheet (annual, 2024-05-31) — Other Properties: 5705729.00
IMR.V balance_sheet (annual, 2024-05-31) — Payables: 597287.00
IMR.V balance_sheet (annual, 2024-05-31) — Payables And Accrued Expenses: 597287.00
IMR.V balance_sheet (annual, 2024-05-31) — Prepaid Assets: 64449.00
IMR.V income_statement (annual, 2024-05-31) — Pretax Income: -2264170.00
IMR.V cash_flow (annual, 2024-05-31) — Proceeds From Stock Option Exercised: 0.00
IMR.V cash_flow (annual, 2024-05-31) — Purchase Of PPE: -393623.00
IMR.V balance_sheet (annual, 2024-05-31) — Receivables: 8630.00
IMR.V income_statement (annual, 2024-05-31) — Reconciled Cost Of Revenue: 1778.00
IMR.V income_statement (annual, 2024-05-31) — Reconciled Depreciation: 1778.00
IMR.V income_statement (annual, 2024-05-31) — Rent And Landing Fees: 18000.00
IMR.V income_statement (annual, 2024-05-31) — Rent Expense Supplemental: 18000.00
IMR.V balance_sheet (annual, 2024-05-31) — Retained Earnings: -49013073.00
IMR.V income_statement (annual, 2024-05-31) — Salaries And Wages: 22946.00
IMR.V income_statement (annual, 2024-05-31) — Selling And Marketing Expense: 461539.00
IMR.V income_statement (annual, 2024-05-31) — Selling General And Administration: 1017498.00
IMR.V balance_sheet (annual, 2024-05-31) — Share Issued: 5607960.00
IMR.V income_statement (annual, 2024-05-31) — Special Income Charges: -1189513.00
IMR.V cash_flow (annual, 2024-05-31) — Stock Based Compensation: 22946.00
IMR.V balance_sheet (annual, 2024-05-31) — Stockholders Equity: 5116503.00
IMR.V balance_sheet (annual, 2024-05-31) — Tangible Book Value: 5116503.00
IMR.V income_statement (annual, 2024-05-31) — Tax Effect Of Unusual Items: 0.00
IMR.V income_statement (annual, 2024-05-31) — Tax Rate For Calcs: 0.00
IMR.V balance_sheet (annual, 2024-05-31) — Total Assets: 5795327.00
IMR.V balance_sheet (annual, 2024-05-31) — Total Capitalization: 5116503.00
IMR.V balance_sheet (annual, 2024-05-31) — Total Equity Gross Minority Interest: 5116503.00
IMR.V income_statement (annual, 2024-05-31) — Total Expenses: 1101265.00
IMR.V balance_sheet (annual, 2024-05-31) — Total Liabilities Net Minority Interest: 678824.00
IMR.V balance_sheet (annual, 2024-05-31) — Total Non Current Assets: 5709879.00
IMR.V balance_sheet (annual, 2024-05-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IMR.V income_statement (annual, 2024-05-31) — Total Operating Income As Reported: -1117919.00
IMR.V income_statement (annual, 2024-05-31) — Total Unusual Items: -1189513.00
IMR.V income_statement (annual, 2024-05-31) — Total Unusual Items Excluding Goodwill: -1189513.00
IMR.V balance_sheet (annual, 2024-05-31) — Working Capital: -593376.00
IMR.V income_statement (quarterly, 2024-11-30) — +Operating Expense: 159711.00
IMR.V income_statement (quarterly, 2024-11-30) — +Total Revenue: 0.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Accounts Payable: 543789.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Accounts Receivable: 6825.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Accumulated Depreciation: -25518.00
IMR.V income_statement (quarterly, 2024-11-30) — Basic Average Shares: 5607960.00
IMR.V income_statement (quarterly, 2024-11-30) — Basic EPS: -0.03
IMR.V cash_flow (quarterly, 2024-11-30) — Beginning Cash Position: 10414.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Capital Stock: 49454484.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Cash And Cash Equivalents: 43176.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Cash Cash Equivalents And Short Term Investments: 43176.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Cash Financial: 43176.00
IMR.V cash_flow (quarterly, 2024-11-30) — Cash Flow From Continuing Investing Activities: -2021.00
IMR.V cash_flow (quarterly, 2024-11-30) — Cash Flow From Continuing Operating Activities: -5267.00
IMR.V cash_flow (quarterly, 2024-11-30) — Change In Account Payable: 69517.00
IMR.V cash_flow (quarterly, 2024-11-30) — Change In Payable: 145117.00
IMR.V cash_flow (quarterly, 2024-11-30) — Change In Payables And Accrued Expense: 145117.00
IMR.V cash_flow (quarterly, 2024-11-30) — Change In Prepaid Assets: 7176.00
IMR.V cash_flow (quarterly, 2024-11-30) — Change In Receivables: 2151.00
IMR.V cash_flow (quarterly, 2024-11-30) — Change In Working Capital: 154444.00
IMR.V cash_flow (quarterly, 2024-11-30) — Changes In Cash: 32762.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Common Stock: 49454484.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Common Stock Equity: 4878593.00
IMR.V cash_flow (quarterly, 2024-11-30) — Common Stock Issuance: 0.00
IMR.V income_statement (quarterly, 2024-11-30) — Cost Of Revenue: 311.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Current Assets: 89797.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Current Liabilities: 938416.00
IMR.V cash_flow (quarterly, 2024-11-30) — Depreciation: 311.00
IMR.V cash_flow (quarterly, 2024-11-30) — Depreciation Amortization Depletion: 311.00
IMR.V cash_flow (quarterly, 2024-11-30) — Depreciation And Amortization: 311.00
IMR.V income_statement (quarterly, 2024-11-30) — Diluted Average Shares: 5607960.00
IMR.V income_statement (quarterly, 2024-11-30) — Diluted EPS: -0.03
IMR.V income_statement (quarterly, 2024-11-30) — Diluted NI Availto Com Stockholders: -146884.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Dueto Related Parties Current: 326717.00
IMR.V income_statement (quarterly, 2024-11-30) — EBIT: -160022.00
IMR.V income_statement (quarterly, 2024-11-30) — EBITDA: -159711.00
IMR.V cash_flow (quarterly, 2024-11-30) — End Cash Position: 43176.00
IMR.V cash_flow (quarterly, 2024-11-30) — Free Cash Flow: -7288.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Gains Losses Not Affecting Retained Earnings: 4677146.00
IMR.V income_statement (quarterly, 2024-11-30) — General And Administrative Expense: 152912.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Gross PPE: 5752730.00
IMR.V income_statement (quarterly, 2024-11-30) — Gross Profit: -311.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Invested Capital: 4878593.00
IMR.V cash_flow (quarterly, 2024-11-30) — Investing Cash Flow: -2021.00
IMR.V cash_flow (quarterly, 2024-11-30) — Issuance Of Capital Stock: 0.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Machinery Furniture Equipment: 29046.00
IMR.V cash_flow (quarterly, 2024-11-30) — Net Common Stock Issuance: 0.00
IMR.V income_statement (quarterly, 2024-11-30) — Net Income: -146884.00
IMR.V income_statement (quarterly, 2024-11-30) — Net Income Common Stockholders: -146884.00
IMR.V income_statement (quarterly, 2024-11-30) — Net Income Continuous Operations: -146884.00
IMR.V income_statement (quarterly, 2024-11-30) — Net Income From Continuing And Discontinued Operation: -146884.00
IMR.V income_statement (quarterly, 2024-11-30) — Net Income From Continuing Operation Net Minority Interest: -146884.00
IMR.V cash_flow (quarterly, 2024-11-30) — Net Income From Continuing Operations: -146884.00
IMR.V income_statement (quarterly, 2024-11-30) — Net Income Including Noncontrolling Interests: -146884.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Net PPE: 5727212.00
IMR.V cash_flow (quarterly, 2024-11-30) — Net PPE Purchase And Sale: -2021.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Net Tangible Assets: 4878593.00
IMR.V income_statement (quarterly, 2024-11-30) — Normalized EBITDA: -159711.00
IMR.V income_statement (quarterly, 2024-11-30) — Normalized Income: -146884.00
IMR.V cash_flow (quarterly, 2024-11-30) — Operating Cash Flow: -5267.00
IMR.V income_statement (quarterly, 2024-11-30) — Operating Income: -160022.00
IMR.V income_statement (quarterly, 2024-11-30) — Operating Revenue: 0.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Ordinary Shares Number: 5607960.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Other Current Liabilities: 67910.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Other Equity Interest: 40050.00
IMR.V income_statement (quarterly, 2024-11-30) — Other Gand A: 148412.00
IMR.V income_statement (quarterly, 2024-11-30) — Other Income Expense: 13138.00
IMR.V cash_flow (quarterly, 2024-11-30) — Other Non Cash Items: -13138.00
IMR.V income_statement (quarterly, 2024-11-30) — Other Non Operating Income Expenses: 13138.00
IMR.V income_statement (quarterly, 2024-11-30) — Other Operating Expenses: 5593.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Other Properties: 5723684.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Payables: 870506.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Payables And Accrued Expenses: 870506.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Prepaid Assets: 39796.00
IMR.V income_statement (quarterly, 2024-11-30) — Pretax Income: -146884.00
IMR.V cash_flow (quarterly, 2024-11-30) — Purchase Of PPE: -2021.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Receivables: 6825.00
IMR.V income_statement (quarterly, 2024-11-30) — Reconciled Cost Of Revenue: 311.00
IMR.V income_statement (quarterly, 2024-11-30) — Reconciled Depreciation: 311.00
IMR.V income_statement (quarterly, 2024-11-30) — Rent And Landing Fees: 4500.00
IMR.V income_statement (quarterly, 2024-11-30) — Rent Expense Supplemental: 4500.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Retained Earnings: -49293087.00
IMR.V income_statement (quarterly, 2024-11-30) — Salaries And Wages: 0.00
IMR.V income_statement (quarterly, 2024-11-30) — Selling And Marketing Expense: 1206.00
IMR.V income_statement (quarterly, 2024-11-30) — Selling General And Administration: 154118.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Share Issued: 5607960.00
IMR.V cash_flow (quarterly, 2024-11-30) — Stock Based Compensation: 0.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Stockholders Equity: 4878593.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Tangible Book Value: 4878593.00
IMR.V income_statement (quarterly, 2024-11-30) — Tax Effect Of Unusual Items: 0.00
IMR.V income_statement (quarterly, 2024-11-30) — Tax Rate For Calcs: 0.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Total Assets: 5817009.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Total Capitalization: 4878593.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Total Equity Gross Minority Interest: 4878593.00
IMR.V income_statement (quarterly, 2024-11-30) — Total Expenses: 160022.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Total Liabilities Net Minority Interest: 938416.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Total Non Current Assets: 5727212.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Total Non Current Liabilities Net Minority Interest: 0.00
IMR.V income_statement (quarterly, 2024-11-30) — Total Operating Income As Reported: -160022.00
IMR.V balance_sheet (quarterly, 2024-11-30) — Working Capital: -848619.00
IMR.V income_statement (quarterly, 2025-02-28) — +Operating Expense: 410941.00
IMR.V income_statement (quarterly, 2025-02-28) — +Total Revenue: 0.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Accounts Payable: 1303956.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Accounts Receivable: 43355.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Accumulated Depreciation: -25829.00
IMR.V income_statement (quarterly, 2025-02-28) — Basic Average Shares: 9082049.00
IMR.V income_statement (quarterly, 2025-02-28) — Basic EPS: -0.04
IMR.V cash_flow (quarterly, 2025-02-28) — Beginning Cash Position: 43176.00
IMR.V cash_flow (quarterly, 2025-02-28) — Capital Expenditure: -107967.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Capital Stock: 50073909.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Cash And Cash Equivalents: 37606.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Cash Cash Equivalents And Short Term Investments: 37606.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Cash Financial: 37606.00
IMR.V cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Financing Activities: 608375.00
IMR.V cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Investing Activities: -107967.00
IMR.V cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Operating Activities: -505978.00
IMR.V cash_flow (quarterly, 2025-02-28) — Change In Account Payable: 55704.00
IMR.V cash_flow (quarterly, 2025-02-28) — Change In Payable: -107970.00
IMR.V cash_flow (quarterly, 2025-02-28) — Change In Payables And Accrued Expense: -107970.00
IMR.V cash_flow (quarterly, 2025-02-28) — Change In Prepaid Assets: -46296.00
IMR.V cash_flow (quarterly, 2025-02-28) — Change In Receivables: -36530.00
IMR.V cash_flow (quarterly, 2025-02-28) — Change In Working Capital: -190796.00
IMR.V cash_flow (quarterly, 2025-02-28) — Changes In Cash: -5570.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Common Stock: 50073909.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Common Stock Equity: 5239385.00
IMR.V cash_flow (quarterly, 2025-02-28) — Common Stock Issuance: 670003.00
IMR.V income_statement (quarterly, 2025-02-28) — Cost Of Revenue: 311.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Current Assets: 167053.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Current Liabilities: 1466999.00
IMR.V cash_flow (quarterly, 2025-02-28) — Depreciation: 311.00
IMR.V cash_flow (quarterly, 2025-02-28) — Depreciation Amortization Depletion: 311.00
IMR.V cash_flow (quarterly, 2025-02-28) — Depreciation And Amortization: 311.00
IMR.V income_statement (quarterly, 2025-02-28) — Diluted Average Shares: 9082049.00
IMR.V income_statement (quarterly, 2025-02-28) — Diluted EPS: -0.04
IMR.V income_statement (quarterly, 2025-02-28) — Diluted NI Availto Com Stockholders: -392583.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Dueto Related Parties Current: 163043.00
IMR.V income_statement (quarterly, 2025-02-28) — EBIT: -343342.00
IMR.V income_statement (quarterly, 2025-02-28) — EBITDA: -343031.00
IMR.V cash_flow (quarterly, 2025-02-28) — End Cash Position: 37606.00
IMR.V cash_flow (quarterly, 2025-02-28) — Financing Cash Flow: 608375.00
IMR.V cash_flow (quarterly, 2025-02-28) — Free Cash Flow: -613945.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Gains Losses Not Affecting Retained Earnings: 4851146.00
IMR.V income_statement (quarterly, 2025-02-28) — General And Administrative Expense: 320368.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Gross PPE: 6565160.00
IMR.V income_statement (quarterly, 2025-02-28) — Gross Profit: -311.00
IMR.V income_statement (quarterly, 2025-02-28) — Impairment Of Capital Assets: 0.00
IMR.V income_statement (quarterly, 2025-02-28) — Interest Expense: 49241.00
IMR.V income_statement (quarterly, 2025-02-28) — Interest Expense Non Operating: 49241.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Invested Capital: 5239385.00
IMR.V cash_flow (quarterly, 2025-02-28) — Investing Cash Flow: -107967.00
IMR.V cash_flow (quarterly, 2025-02-28) — Issuance Of Capital Stock: 670003.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Machinery Furniture Equipment: 29046.00
IMR.V cash_flow (quarterly, 2025-02-28) — Net Common Stock Issuance: 670003.00
IMR.V income_statement (quarterly, 2025-02-28) — Net Income: -392583.00
IMR.V income_statement (quarterly, 2025-02-28) — Net Income Common Stockholders: -392583.00
IMR.V income_statement (quarterly, 2025-02-28) — Net Income Continuous Operations: -392583.00
IMR.V income_statement (quarterly, 2025-02-28) — Net Income From Continuing And Discontinued Operation: -392583.00
IMR.V income_statement (quarterly, 2025-02-28) — Net Income From Continuing Operation Net Minority Interest: -392583.00
IMR.V cash_flow (quarterly, 2025-02-28) — Net Income From Continuing Operations: -392583.00
IMR.V income_statement (quarterly, 2025-02-28) — Net Income Including Noncontrolling Interests: -392583.00
IMR.V income_statement (quarterly, 2025-02-28) — Net Interest Income: -49241.00
IMR.V income_statement (quarterly, 2025-02-28) — Net Non Operating Interest Income Expense: -49241.00
IMR.V cash_flow (quarterly, 2025-02-28) — Net Other Financing Charges: -61628.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Net PPE: 6539331.00
IMR.V cash_flow (quarterly, 2025-02-28) — Net PPE Purchase And Sale: -107967.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Net Tangible Assets: 5239385.00
IMR.V income_statement (quarterly, 2025-02-28) — Normalized EBITDA: -343031.00
IMR.V income_statement (quarterly, 2025-02-28) — Normalized Income: -392583.00
IMR.V cash_flow (quarterly, 2025-02-28) — Operating Cash Flow: -505978.00
IMR.V income_statement (quarterly, 2025-02-28) — Operating Income: -411252.00
IMR.V income_statement (quarterly, 2025-02-28) — Operating Revenue: 0.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Ordinary Shares Number: 10074646.00
IMR.V income_statement (quarterly, 2025-02-28) — Other Gand A: 170868.00
IMR.V income_statement (quarterly, 2025-02-28) — Other Income Expense: 67910.00
IMR.V cash_flow (quarterly, 2025-02-28) — Other Non Cash Items: -67910.00
IMR.V income_statement (quarterly, 2025-02-28) — Other Non Operating Income Expenses: 67910.00
IMR.V income_statement (quarterly, 2025-02-28) — Other Operating Expenses: 16176.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Other Properties: 6536114.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Payables: 1466999.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Payables And Accrued Expenses: 1466999.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Prepaid Assets: 86092.00
IMR.V income_statement (quarterly, 2025-02-28) — Pretax Income: -392583.00
IMR.V cash_flow (quarterly, 2025-02-28) — Proceeds From Stock Option Exercised: 0.00
IMR.V cash_flow (quarterly, 2025-02-28) — Purchase Of PPE: -107967.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Receivables: 43355.00
IMR.V income_statement (quarterly, 2025-02-28) — Reconciled Cost Of Revenue: 311.00
IMR.V income_statement (quarterly, 2025-02-28) — Reconciled Depreciation: 311.00
IMR.V income_statement (quarterly, 2025-02-28) — Rent And Landing Fees: 4500.00
IMR.V income_statement (quarterly, 2025-02-28) — Rent Expense Supplemental: 4500.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Retained Earnings: -49685670.00
IMR.V income_statement (quarterly, 2025-02-28) — Salaries And Wages: 145000.00
IMR.V income_statement (quarterly, 2025-02-28) — Selling And Marketing Expense: 74397.00
IMR.V income_statement (quarterly, 2025-02-28) — Selling General And Administration: 394765.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Share Issued: 10074646.00
IMR.V income_statement (quarterly, 2025-02-28) — Special Income Charges: 0.00
IMR.V cash_flow (quarterly, 2025-02-28) — Stock Based Compensation: 145000.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Stockholders Equity: 5239385.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Tangible Book Value: 5239385.00
IMR.V income_statement (quarterly, 2025-02-28) — Tax Effect Of Unusual Items: 0.00
IMR.V income_statement (quarterly, 2025-02-28) — Tax Rate For Calcs: 0.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Total Assets: 6706384.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Total Capitalization: 5239385.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Total Equity Gross Minority Interest: 5239385.00
IMR.V income_statement (quarterly, 2025-02-28) — Total Expenses: 411252.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Total Liabilities Net Minority Interest: 1466999.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Total Non Current Assets: 6539331.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Total Non Current Liabilities Net Minority Interest: 0.00
IMR.V income_statement (quarterly, 2025-02-28) — Total Operating Income As Reported: -460493.00
IMR.V income_statement (quarterly, 2025-02-28) — Total Unusual Items: 0.00
IMR.V income_statement (quarterly, 2025-02-28) — Total Unusual Items Excluding Goodwill: 0.00
IMR.V balance_sheet (quarterly, 2025-02-28) — Working Capital: -1299946.00
IMR.V income_statement (quarterly, 2025-11-30) — +Operating Expense: 737255.00
IMR.V income_statement (quarterly, 2025-11-30) — +Total Revenue: 0.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Accounts Payable: 992249.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Accounts Receivable: 77946.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Accumulated Depreciation: -26576.00
IMR.V income_statement (quarterly, 2025-11-30) — Basic Average Shares: 36158313.00
IMR.V income_statement (quarterly, 2025-11-30) — Basic EPS: -0.02
IMR.V cash_flow (quarterly, 2025-11-30) — Beginning Cash Position: 704298.00
IMR.V cash_flow (quarterly, 2025-11-30) — Capital Expenditure: -271763.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Capital Stock: 52430252.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 49573.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 49573.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Cash Financial: 49573.00
IMR.V cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Financing Activities: 10000.00
IMR.V cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Investing Activities: -271763.00
IMR.V cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Operating Activities: -392962.00
IMR.V cash_flow (quarterly, 2025-11-30) — Change In Account Payable: -66340.00
IMR.V cash_flow (quarterly, 2025-11-30) — Change In Payable: -126598.00
IMR.V cash_flow (quarterly, 2025-11-30) — Change In Payables And Accrued Expense: -126598.00
IMR.V cash_flow (quarterly, 2025-11-30) — Change In Prepaid Assets: -26994.00
IMR.V cash_flow (quarterly, 2025-11-30) — Change In Receivables: 276885.00
IMR.V cash_flow (quarterly, 2025-11-30) — Change In Working Capital: 123293.00
IMR.V cash_flow (quarterly, 2025-11-30) — Changes In Cash: -654725.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Common Stock: 52430252.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 6338333.00
IMR.V cash_flow (quarterly, 2025-11-30) — Common Stock Issuance: 0.00
IMR.V income_statement (quarterly, 2025-11-30) — Cost Of Revenue: 218.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Current Assets: 456876.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Current Liabilities: 1097649.00
IMR.V cash_flow (quarterly, 2025-11-30) — Depreciation: 218.00
IMR.V cash_flow (quarterly, 2025-11-30) — Depreciation Amortization Depletion: 218.00
IMR.V cash_flow (quarterly, 2025-11-30) — Depreciation And Amortization: 218.00
IMR.V income_statement (quarterly, 2025-11-30) — Diluted Average Shares: 36158313.00
IMR.V income_statement (quarterly, 2025-11-30) — Diluted EPS: -0.02
IMR.V income_statement (quarterly, 2025-11-30) — Diluted NI Availto Com Stockholders: -737473.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Dueto Related Parties Current: 105400.00
IMR.V income_statement (quarterly, 2025-11-30) — EBIT: -737473.00
IMR.V income_statement (quarterly, 2025-11-30) — EBITDA: -737255.00
IMR.V cash_flow (quarterly, 2025-11-30) — End Cash Position: 49573.00
IMR.V cash_flow (quarterly, 2025-11-30) — Financing Cash Flow: 10000.00
IMR.V cash_flow (quarterly, 2025-11-30) — Free Cash Flow: -664725.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Gains Losses Not Affecting Retained Earnings: 5415146.00
IMR.V income_statement (quarterly, 2025-11-30) — General And Administrative Expense: 450654.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Gross PPE: 7005682.00
IMR.V income_statement (quarterly, 2025-11-30) — Gross Profit: -218.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Invested Capital: 6338333.00
IMR.V cash_flow (quarterly, 2025-11-30) — Investing Cash Flow: -271763.00
IMR.V cash_flow (quarterly, 2025-11-30) — Issuance Of Capital Stock: 0.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Machinery Furniture Equipment: 29046.00
IMR.V cash_flow (quarterly, 2025-11-30) — Net Common Stock Issuance: 0.00
IMR.V income_statement (quarterly, 2025-11-30) — Net Income: -737473.00
IMR.V income_statement (quarterly, 2025-11-30) — Net Income Common Stockholders: -737473.00
IMR.V income_statement (quarterly, 2025-11-30) — Net Income Continuous Operations: -737473.00
IMR.V income_statement (quarterly, 2025-11-30) — Net Income From Continuing And Discontinued Operation: -737473.00
IMR.V income_statement (quarterly, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: -737473.00
IMR.V cash_flow (quarterly, 2025-11-30) — Net Income From Continuing Operations: -737473.00
IMR.V income_statement (quarterly, 2025-11-30) — Net Income Including Noncontrolling Interests: -737473.00
IMR.V cash_flow (quarterly, 2025-11-30) — Net Other Financing Charges: 0.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Net PPE: 6979106.00
IMR.V cash_flow (quarterly, 2025-11-30) — Net PPE Purchase And Sale: -271763.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 6338333.00
IMR.V income_statement (quarterly, 2025-11-30) — Normalized EBITDA: -737255.00
IMR.V income_statement (quarterly, 2025-11-30) — Normalized Income: -737473.00
IMR.V cash_flow (quarterly, 2025-11-30) — Operating Cash Flow: -392962.00
IMR.V income_statement (quarterly, 2025-11-30) — Operating Income: -737473.00
IMR.V income_statement (quarterly, 2025-11-30) — Operating Revenue: 0.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 36196445.00
IMR.V income_statement (quarterly, 2025-11-30) — Other Gand A: 225154.00
IMR.V income_statement (quarterly, 2025-11-30) — Other Operating Expenses: 17850.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Other Properties: 6976636.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Payables: 1097649.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Payables And Accrued Expenses: 1097649.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Prepaid Assets: 329357.00
IMR.V income_statement (quarterly, 2025-11-30) — Pretax Income: -737473.00
IMR.V cash_flow (quarterly, 2025-11-30) — Purchase Of PPE: -271763.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Receivables: 77946.00
IMR.V income_statement (quarterly, 2025-11-30) — Reconciled Cost Of Revenue: 218.00
IMR.V income_statement (quarterly, 2025-11-30) — Reconciled Depreciation: 218.00
IMR.V income_statement (quarterly, 2025-11-30) — Rent And Landing Fees: 4500.00
IMR.V income_statement (quarterly, 2025-11-30) — Rent Expense Supplemental: 4500.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Retained Earnings: -51507065.00
IMR.V income_statement (quarterly, 2025-11-30) — Salaries And Wages: 221000.00
IMR.V income_statement (quarterly, 2025-11-30) — Selling And Marketing Expense: 268751.00
IMR.V income_statement (quarterly, 2025-11-30) — Selling General And Administration: 719405.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Share Issued: 36196445.00
IMR.V cash_flow (quarterly, 2025-11-30) — Stock Based Compensation: 221000.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 6338333.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 6338333.00
IMR.V income_statement (quarterly, 2025-11-30) — Tax Effect Of Unusual Items: 0.00
IMR.V income_statement (quarterly, 2025-11-30) — Tax Rate For Calcs: 0.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Total Assets: 7435982.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Total Capitalization: 6338333.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 6338333.00
IMR.V income_statement (quarterly, 2025-11-30) — Total Expenses: 737473.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 1097649.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Total Non Current Assets: 6979106.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 0.00
IMR.V income_statement (quarterly, 2025-11-30) — Total Operating Income As Reported: -737473.00
IMR.V balance_sheet (quarterly, 2025-11-30) — Working Capital: -640773.00
IMR.V income_statement (quarterly, 2026-02-28) — +Operating Expense: 354746.00
IMR.V income_statement (quarterly, 2026-02-28) — +Total Revenue: 0.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Accounts Payable: 827893.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Accounts Receivable: 11911.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Accumulated Depreciation: -26794.00
IMR.V income_statement (quarterly, 2026-02-28) — Basic Average Shares: 39574417.00
IMR.V income_statement (quarterly, 2026-02-28) — Basic EPS: -0.01
IMR.V cash_flow (quarterly, 2026-02-28) — Beginning Cash Position: 49573.00
IMR.V cash_flow (quarterly, 2026-02-28) — Capital Expenditure: -353053.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Capital Stock: 52906755.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Cash And Cash Equivalents: 39662.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Cash Cash Equivalents And Short Term Investments: 39662.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Cash Financial: 39662.00
IMR.V cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Financing Activities: 503503.00
IMR.V cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Investing Activities: -353053.00
IMR.V cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Operating Activities: -160361.00
IMR.V cash_flow (quarterly, 2026-02-28) — Change In Account Payable: -65785.00
IMR.V cash_flow (quarterly, 2026-02-28) — Change In Payable: -65785.00
IMR.V cash_flow (quarterly, 2026-02-28) — Change In Payables And Accrued Expense: -65785.00
IMR.V cash_flow (quarterly, 2026-02-28) — Change In Prepaid Assets: 107066.00
IMR.V cash_flow (quarterly, 2026-02-28) — Change In Receivables: 66035.00
IMR.V cash_flow (quarterly, 2026-02-28) — Change In Working Capital: 107316.00
IMR.V cash_flow (quarterly, 2026-02-28) — Changes In Cash: -9911.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Common Stock: 52906755.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Common Stock Equity: 6573941.00
IMR.V cash_flow (quarterly, 2026-02-28) — Common Stock Issuance: 541401.00
IMR.V income_statement (quarterly, 2026-02-28) — Cost Of Revenue: 218.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Current Assets: 273864.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Current Liabilities: 933293.00
IMR.V cash_flow (quarterly, 2026-02-28) — Depreciation: 218.00
IMR.V cash_flow (quarterly, 2026-02-28) — Depreciation Amortization Depletion: 218.00
IMR.V cash_flow (quarterly, 2026-02-28) — Depreciation And Amortization: 218.00
IMR.V income_statement (quarterly, 2026-02-28) — Diluted Average Shares: 39574417.00
IMR.V income_statement (quarterly, 2026-02-28) — Diluted EPS: -0.01
IMR.V income_statement (quarterly, 2026-02-28) — Diluted NI Availto Com Stockholders: -354964.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Dueto Related Parties Current: 105400.00
IMR.V income_statement (quarterly, 2026-02-28) — EBIT: -354964.00
IMR.V income_statement (quarterly, 2026-02-28) — EBITDA: -354746.00
IMR.V cash_flow (quarterly, 2026-02-28) — End Cash Position: 39662.00
IMR.V cash_flow (quarterly, 2026-02-28) — Financing Cash Flow: 503503.00
IMR.V cash_flow (quarterly, 2026-02-28) — Free Cash Flow: -513414.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Gains Losses Not Affecting Retained Earnings: 5529215.00
IMR.V income_statement (quarterly, 2026-02-28) — General And Administrative Expense: 272631.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Gross PPE: 7260164.00
IMR.V income_statement (quarterly, 2026-02-28) — Gross Profit: -218.00
IMR.V income_statement (quarterly, 2026-02-28) — Interest Expense: 0.00
IMR.V income_statement (quarterly, 2026-02-28) — Interest Expense Non Operating: 0.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Invested Capital: 6573941.00
IMR.V cash_flow (quarterly, 2026-02-28) — Investing Cash Flow: -353053.00
IMR.V cash_flow (quarterly, 2026-02-28) — Issuance Of Capital Stock: 541401.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Machinery Furniture Equipment: 29046.00
IMR.V cash_flow (quarterly, 2026-02-28) — Net Common Stock Issuance: 541401.00
IMR.V income_statement (quarterly, 2026-02-28) — Net Income: -354964.00
IMR.V income_statement (quarterly, 2026-02-28) — Net Income Common Stockholders: -354964.00
IMR.V income_statement (quarterly, 2026-02-28) — Net Income Continuous Operations: -354964.00
IMR.V income_statement (quarterly, 2026-02-28) — Net Income From Continuing And Discontinued Operation: -354964.00
IMR.V income_statement (quarterly, 2026-02-28) — Net Income From Continuing Operation Net Minority Interest: -354964.00
IMR.V cash_flow (quarterly, 2026-02-28) — Net Income From Continuing Operations: -354964.00
IMR.V income_statement (quarterly, 2026-02-28) — Net Income Including Noncontrolling Interests: -354964.00
IMR.V income_statement (quarterly, 2026-02-28) — Net Interest Income: 0.00
IMR.V income_statement (quarterly, 2026-02-28) — Net Non Operating Interest Income Expense: 0.00
IMR.V cash_flow (quarterly, 2026-02-28) — Net Other Financing Charges: -37898.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Net PPE: 7233370.00
IMR.V cash_flow (quarterly, 2026-02-28) — Net PPE Purchase And Sale: -353053.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Net Tangible Assets: 6573941.00
IMR.V income_statement (quarterly, 2026-02-28) — Normalized EBITDA: -354746.00
IMR.V income_statement (quarterly, 2026-02-28) — Normalized Income: -354964.00
IMR.V cash_flow (quarterly, 2026-02-28) — Operating Cash Flow: -160361.00
IMR.V income_statement (quarterly, 2026-02-28) — Operating Income: -354964.00
IMR.V income_statement (quarterly, 2026-02-28) — Operating Revenue: 0.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Ordinary Shares Number: 40361068.00
IMR.V income_statement (quarterly, 2026-02-28) — Other Gand A: 181062.00
IMR.V income_statement (quarterly, 2026-02-28) — Other Operating Expenses: 15534.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Other Properties: 7231118.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Payables: 933293.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Payables And Accrued Expenses: 933293.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Prepaid Assets: 222291.00
IMR.V income_statement (quarterly, 2026-02-28) — Pretax Income: -354964.00
IMR.V cash_flow (quarterly, 2026-02-28) — Proceeds From Stock Option Exercised: 0.00
IMR.V cash_flow (quarterly, 2026-02-28) — Purchase Of PPE: -353053.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Receivables: 11911.00
IMR.V income_statement (quarterly, 2026-02-28) — Reconciled Cost Of Revenue: 218.00
IMR.V income_statement (quarterly, 2026-02-28) — Reconciled Depreciation: 218.00
IMR.V income_statement (quarterly, 2026-02-28) — Rent And Landing Fees: 4500.00
IMR.V income_statement (quarterly, 2026-02-28) — Rent Expense Supplemental: 4500.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Retained Earnings: -51862029.00
IMR.V income_statement (quarterly, 2026-02-28) — Salaries And Wages: 87069.00
IMR.V income_statement (quarterly, 2026-02-28) — Selling And Marketing Expense: 66581.00
IMR.V income_statement (quarterly, 2026-02-28) — Selling General And Administration: 339212.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Share Issued: 40361068.00
IMR.V cash_flow (quarterly, 2026-02-28) — Stock Based Compensation: 87069.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Stockholders Equity: 6573941.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Tangible Book Value: 6573941.00
IMR.V income_statement (quarterly, 2026-02-28) — Tax Effect Of Unusual Items: 0.00
IMR.V income_statement (quarterly, 2026-02-28) — Tax Rate For Calcs: 0.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Total Assets: 7507234.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Total Capitalization: 6573941.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Total Equity Gross Minority Interest: 6573941.00
IMR.V income_statement (quarterly, 2026-02-28) — Total Expenses: 354964.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Total Liabilities Net Minority Interest: 933293.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Total Non Current Assets: 7233370.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Total Non Current Liabilities Net Minority Interest: 0.00
IMR.V income_statement (quarterly, 2026-02-28) — Total Operating Income As Reported: -354964.00
IMR.V balance_sheet (quarterly, 2026-02-28) — Working Capital: -659429.00
IMRN income_statement (annual, 2021-06-30) — Basic Average Shares: 5526556.00
IMRN cash_flow (annual, 2021-06-30) — Capital Expenditure: -6630.00
IMRN balance_sheet (annual, 2021-06-30) — Current Capital Lease Obligation: 20498.00
IMRN balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 20498.00
IMRN balance_sheet (annual, 2021-06-30) — Current Provisions: 213024.00
IMRN cash_flow (annual, 2021-06-30) — Issuance Of Debt: 212794.00
IMRN cash_flow (annual, 2021-06-30) — Long Term Debt Issuance: 212794.00
IMRN cash_flow (annual, 2021-06-30) — Net Other Financing Charges: -2746871.00
IMRN cash_flow (annual, 2021-06-30) — Other Cash Receiptsfrom Operating Activities: 358280.00
IMRN balance_sheet (annual, 2021-06-30) — Other Current Assets: 78258.00
IMRN balance_sheet (annual, 2021-06-30) — Other Current Liabilities: 20498.00
IMRN income_statement (annual, 2021-06-30) — Other Special Charges: -161600.00
IMRN income_statement (annual, 2021-06-30) — Other Taxes: -356209.00
IMRN income_statement (annual, 2021-06-30) — Rent And Landing Fees: 0.00
IMRN income_statement (annual, 2021-06-30) — Rent Expense Supplemental: 0.00
IMRN income_statement (annual, 2022-06-30) — +Operating Expense: 3640915.00
IMRN income_statement (annual, 2022-06-30) — +Total Revenue: 765193.00
IMRN balance_sheet (annual, 2022-06-30) — Accounts Payable: 720867.00
IMRN balance_sheet (annual, 2022-06-30) — Accounts Receivable: 208345.00
IMRN balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -402193.00
IMRN balance_sheet (annual, 2022-06-30) — Allowance For Doubtful Accounts Receivable: -8809.00
IMRN income_statement (annual, 2022-06-30) — Basic Average Shares: 5689492.00
IMRN income_statement (annual, 2022-06-30) — Basic EPS: -0.50
IMRN cash_flow (annual, 2022-06-30) — Beginning Cash Position: 25047281.00
IMRN cash_flow (annual, 2022-06-30) — Capital Expenditure: -10048.00
IMRN balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 209787.00
IMRN balance_sheet (annual, 2022-06-30) — Capital Stock: 88436263.00
IMRN balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 22110278.00
IMRN balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 22110278.00
IMRN cash_flow (annual, 2022-06-30) — Cash Dividends Paid: 0.00
IMRN balance_sheet (annual, 2022-06-30) — Cash Financial: 22110278.00
IMRN cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: -42448.00
IMRN cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: 11737.00
IMRN cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -3147793.00
IMRN cash_flow (annual, 2022-06-30) — Changes In Cash: -3178504.00
IMRN cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -4629139.00
IMRN cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 1481346.00
IMRN balance_sheet (annual, 2022-06-30) — Common Stock: 88436263.00
IMRN balance_sheet (annual, 2022-06-30) — Common Stock Equity: 23177401.00
IMRN cash_flow (annual, 2022-06-30) — Common Stock Issuance: 0.00
IMRN income_statement (annual, 2022-06-30) — Cost Of Revenue: 241691.00
IMRN balance_sheet (annual, 2022-06-30) — Current Accrued Expenses: 411913.00
IMRN balance_sheet (annual, 2022-06-30) — Current Assets: 23672152.00
IMRN balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 34376.00
IMRN balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 34376.00
IMRN balance_sheet (annual, 2022-06-30) — Current Deferred Liabilities: 0.00
IMRN balance_sheet (annual, 2022-06-30) — Current Deferred Revenue: 0.00
IMRN balance_sheet (annual, 2022-06-30) — Current Liabilities: 1502976.00
IMRN balance_sheet (annual, 2022-06-30) — Current Provisions: 95931.00
IMRN income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 42606.00
IMRN income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 42606.00
IMRN income_statement (annual, 2022-06-30) — Depreciation Income Statement: 42606.00
IMRN income_statement (annual, 2022-06-30) — Diluted Average Shares: 5689492.00
IMRN income_statement (annual, 2022-06-30) — Diluted EPS: -0.50
IMRN income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: -2854254.00
IMRN income_statement (annual, 2022-06-30) — EBIT: -2848070.00
IMRN income_statement (annual, 2022-06-30) — EBITDA: -2805464.00
IMRN income_statement (annual, 2022-06-30) — Earnings From Equity Interest: 0.00
IMRN cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: 241501.00
IMRN balance_sheet (annual, 2022-06-30) — Employee Benefits: 36.00
IMRN cash_flow (annual, 2022-06-30) — End Cash Position: 22110278.00
IMRN cash_flow (annual, 2022-06-30) — Financing Cash Flow: -42448.00
IMRN balance_sheet (annual, 2022-06-30) — Finished Goods: 64923.00
IMRN cash_flow (annual, 2022-06-30) — Free Cash Flow: -3157841.00
IMRN income_statement (annual, 2022-06-30) — Gain On Sale Of Security: 247558.00
IMRN balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 3166419.00
IMRN income_statement (annual, 2022-06-30) — General And Administrative Expense: 3472973.00
IMRN balance_sheet (annual, 2022-06-30) — Gross Accounts Receivable: 217154.00
IMRN balance_sheet (annual, 2022-06-30) — Gross PPE: 628929.00
IMRN income_statement (annual, 2022-06-30) — Gross Profit: 523502.00
IMRN income_statement (annual, 2022-06-30) — Insurance And Claims: 401121.00
IMRN income_statement (annual, 2022-06-30) — Interest Expense: 6184.00
IMRN income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 6184.00
IMRN income_statement (annual, 2022-06-30) — Interest Income: 21785.00
IMRN income_statement (annual, 2022-06-30) — Interest Income Non Operating: 21785.00
IMRN cash_flow (annual, 2022-06-30) — Interest Paid Cff: -6184.00
IMRN cash_flow (annual, 2022-06-30) — Interest Received Cfi: 21785.00
IMRN balance_sheet (annual, 2022-06-30) — Inventory: 326578.00
IMRN balance_sheet (annual, 2022-06-30) — Invested Capital: 23177401.00
IMRN cash_flow (annual, 2022-06-30) — Investing Cash Flow: 11737.00
IMRN balance_sheet (annual, 2022-06-30) — Investments And Advances: 0.00
IMRN cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 0.00
IMRN cash_flow (annual, 2022-06-30) — Issuance Of Debt: 0.00
IMRN balance_sheet (annual, 2022-06-30) — Leases: 229031.00
IMRN balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 175411.00
IMRN balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 175411.00
IMRN cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 0.00
IMRN cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -36264.00
IMRN balance_sheet (annual, 2022-06-30) — Long Term Equity Investment: 0.00
IMRN balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 399898.00
IMRN cash_flow (annual, 2022-06-30) — Net Business Purchase And Sale: 0.00
IMRN cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 0.00
IMRN income_statement (annual, 2022-06-30) — Net Income: -2854254.00
IMRN income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -2854254.00
IMRN income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -2854254.00
IMRN income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -2854254.00
IMRN income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -2854254.00
IMRN income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -2854254.00
IMRN income_statement (annual, 2022-06-30) — Net Interest Income: 15601.00
IMRN cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -36264.00
IMRN cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -36264.00
IMRN income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: 15601.00
IMRN balance_sheet (annual, 2022-06-30) — Net PPE: 226736.00
IMRN cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -10048.00
IMRN balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 23177401.00